SYF Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
SYF is not a good buy right now for an impatient investor. The stock is technically oversold and sitting on a key support area (around 72.7), which can spark a short-term bounce, but post-earnings price-target cuts, transition-year guidance, and credit-risk concerns argue against chasing an entry immediately without a proprietary buy signal. Net: HOLD (only becomes a buy if it firmly reclaims the ~76.5 pivot and stabilizes above it).
Price/Levels: SYF closed post-market at 72.63, essentially on S1 support (72.687) and above S2 (70.331), but well below the pivot resistance zone (76.501). This setup implies the stock is in a short-term downswing and is now testing a key support shelf. Momentum: MACD histogram at -0.9 is below zero (bearish), though “negatively contracting” suggests downside momentum is slowing rather than accelerating. RSI: RSI(6) at ~25.6 is oversold (below 30), often consistent with near-term bounce potential—but oversold can persist when fundamentals/guidance disappoint. Moving Averages: Converging MAs point to consolidation after a decline; trend is not decisively turning up yet. Probability/Pattern read-through (provided): next day modestly positive bias (+1.89%), but next week skew negative (-3.79%), with a better 1-month outlook (+3.25%). That aligns with a likely choppy near-term digestion after earnings.
Intellectia Proprietary Trading Signals
Street view: Despite target cuts, multiple firms reiterate Buy/Overweight with targets largely above current price (mid-80s to mid/high-90s), implying meaningful upside if credit stays contained and growth investments pay off.
and just above support (~72.7); a clean break below support would likely invite further selling toward ~70.
Positioning: Put-heavy open interest (slightly) suggests ongoing hedging demand.
Latest quarter: 2025/Q4. Revenue: $5.286B, +3.83% YoY (steady top-line growth). Net income: $730M, -3.05% YoY (profit dollars down, suggesting higher costs/provisions or margin pressure). EPS: 2.04, +6.81% YoY (per-share growth despite lower net income, likely helped by capital actions/share count dynamics). Overall: Growth is present, but profitability quality is mixed given the net income decline and the market’s sensitivity to credit/provision trends in this industry.
Recent trend: The dominant move post-Q4 has been price-target cuts (Truist 92→84 Hold; JPM 86→84 Neutral; RBC 91→85 Sector Perform; Barclays 101→93 Overweight; TD Cowen 100→95 Buy; BTIG 100→96 Buy). There was one notable rating improvement: Compass Point upgraded to Buy (PT 97→96). Wall Street pros: Many Buys/Overweight remain, arguing the selloff is overdone and that investment spending sets up a return to longer-term loan growth targets. Wall Street cons: Caution centers on 2026 growth/spend guidance, lack of further credit-standard easing, and credit/provision uncertainty. Influential/political trading: Hedge funds and insiders show Neutral trends; no recent Congress trading data available.
